Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-963,000
Closed -$38.6M 559
2016
Q4
$38.6M Buy
+963,000
New +$37.2M 0.08% 253
2014
Q2
Sell
-5,285,982
Closed -$114M 541
2014
Q1
$114M Buy
5,285,982
+65,560
+1% +$1.41M 0.17% 150
2013
Q4
$117M Sell
5,220,422
-2,895,078
-36% -$63.8M 0.19% 140
2013
Q3
$168M Buy
8,115,500
+3,883,900
+92% +$82.7M 0.32% 87
2013
Q2
$81.7M Buy
+4,231,600
New +$88.4M 0.17% 142

Other funds holding HOLX

Waddell & Reed Financial's HOLX Position: Q1 2017 in Review

Waddell & Reed Financial sold out of Hologic (HOLX) in Q1 2017, closing a stake of 963,000 shares — an estimated $38.6M sold.

Waddell & Reed Financial first reported a position in HOLX in Q2 2013 and held it in 5 quarters. The position peaked at $168M in Q3 2013. 501 funds tracked by Wall St. Rank hold HOLX as of Q1 2017.

  • Waddell & Reed Financial reported no remaining Hologic position as of Q1 2017 after selling out during the quarter.
  • Waddell & Reed Financial sold 963,000 Hologic shares in Q1 2017, an estimated $38.6M.
  • Waddell & Reed Financial first reported a position in Hologic in Q2 2013 and held it in 5 quarters.
  • Waddell & Reed Financial's Hologic position peaked at $168M in Q3 2013.
  • 501 funds tracked by Wall St. Rank held Hologic as of Q1 2017.

Based on Waddell & Reed Financial's 13F filing for Q1 2017, filed 15 May 2017.